Abstract
PSY59 Variation in Health-Related Quality of Life Associated With Changes in Transfusion Status of Patients With Myelodysplastic Syndromes Across Six Months of Treatment With Azacitidine
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have